Resit SEVİMLİ, Serdar KARAMAN

Clinical results of endoprosthetic reconstructions in metastatic and primary bone tumors

In this study, we aimed to compare the functional outcomes and survival of 38 patients with primary bone and metastatic bone tumors who were reconstructed with endoprosthesis. Thirty-eight patients who underwent endoprosthesis for malign bone tumors 2012- 2015 were included in the study. We retrospectively reviewed 38 patients, eight of whom underwent limb salvage with tumor resection prosthesis of tibia, 21 femur, and 9 humerus. When comparing functional outcomes, the revised Musculoskeletal Tumor Society (MSTS) scoring system was used for all surviving patients. The patients were evaluated in two groups as primary bone tumor and metastatic bone tumor. The mean follow-up period of 32 healthy and alive patients was 38 (12 to 98) months. While 12 patients were primary malign bone tumors, the other 26 patients had bone metastasis. All six patients who died during follow-up had a diagnosis of metastatic bone tumor. Periprosthetic infection was observed in two patients, recurrence tumor in one and prosthetic dislocation in one. It was found that the MSTS score in patients with primary bone tumors (22, 6) was statistically significantly higher than in patients with metastases (17, 6) (p

PDF

___

1. Gebhardt MC, Flugstad DJ, Springfield DS, Mankin HJ. The use of bone allografts for limb salvage in high-grade extremity osteosarkoma. Clin Orthop. 1991;270:181-96.
2. Jeys LM, Grimer RJ, Carter SR, et al. Post-operative infection and increased survival in osteosarcoma patients: are they associated? Ann Surg Oncol. 2007;14:2887-95.
3. Jeys LM, Grimer RJ, Carter SR, Tillman RM. Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg Am. 2005;87:842-9.
4. Henderson ER, Groundland JS, Pala E, et al. Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am. 2011;93:418–29.
5. Foo LS, Hardes J, Henrichs M, et al. Surgical difficulties encountered with use of modular endoprosthesis for limb preserving salvage of failed allograft reconstruction after malignant tumor resection. J Arthroplasty. 2011;26:744-50.
6. Balke M, Ahrens H, Streitbürger A, et al. Modular endoprosthetic reconstructionin malignant bone tumors: indications and limits. Recent Results. Cancer Res. 2009;179:39-50
7. Donati D, Di Liddo M, Zavatta M, et al. Massive bone allograft reconstruction in high-grade osteosarcoma. Clin Orthop. 2000;377:186-94.
8. Enneking WF, Dunham W, et al. A system for the functional evaluation of the reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop. 1993;286:241-61.
9. Rose PS, Shin AY, Bishop AT, et al. Vascularized free fibula transfer for oncologic reconstruction of the humerus. Clin Orthop. 2005;438:80-4.
10. Dormans JP, Ofluoglu O, Erol B, et al. Reconstruction of an intercalary defect with bone transport after resection of Ewing’s sarcoma. Clin Orthop. 2005;434:258-64.
11. Gitelis S, Heligman D, Quill G, Piasecki P. The use of large allografts for tumor reconstruction and salvage of the failed total hip arthroplasty. Clin Orthop. 1988;231:62-70.
12. Brien EW, Terek RM, Healey JH, Lane JM. Allograft reconstruction after proximal tibial resection for bone tumors. Clin Orthop. 1994;303:116-27
13. L. M. Jeys, R. J. Grimer, S. R. Carter, R. M. Tillman. Risk of amputation following limb salvage surgery with endoprosthetic replacement, in a consecutive series of 1261 patients. International Orthopaedics. 2003;27:160–3.
14. Plötz W, Rechl H, Burgkart R, et al. Limb salvage with tumor endoprostheses for malignant tumors of the knee. Clin Orthop Relat Res 2002;405: 207-15.
15. Unwin PS, Cannon SR, Grimer RJ, et al. Aseptic loosening in cemented custom-made prosthetic replacements for bone tumours of the lower limb. J Bone Jt Surg Br. 1996;78:5-13.
16. Marculescu C, Berbari E, Hanssen A, et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis. 2006; 42:471-8.
17. Mavrogenis AF, Pala E, et al. Infected tumor prostheses: Clinical Outcomes of 100 Patients. Surg Infect (Larchmt). 2015;16:267-75.
18. Elisa Pala MD, Giulia Trovarelli MD, Teresa Calabro` MD, Survival of Modern Knee Tumor Megaprostheses: Failures, Functional Results, and a Comparative Statistical Analysis. Clin Orthop Relat Res. 2015;473:891–9.
19. Gosheger G, Gebert C, et al. Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res. 2006;450:164–71.
20. Ruggieri P, Mavrogenis AF, et al. Long term results of fixed-hinge megaprostheses in limb salvage for malignancy. Knee. 2012;19:543–9.
21. Turcotte RE. Endoprosthetic replacements for bone tumors: review of the most recent literature. Curr Opin Orthop. 2007;18:572–8.